“…with the primary antibodies listed in Table S1, that is, glial fibrillary acidic protein (GFAP), ionized calcium-binding adapter molecule 1 (Iba1), cluster of differentiation (CD) 68 and CD163 which are the glial cell markers 5,34 ; GFAP, SRY-box transcription factor 2 (SOX2), Tbox brain protein 2 (TBR2), doublecortin (DCX), tubulin, beta 3 class III (TUBB3), and neuronal nuclei (NeuN), which are the marker proteins of hippocampal granule cell lineage subpopulations 15,[35][36][37] ; proliferating cell nuclear antigen (PCNA), a cell proliferation marker; calbindin-D-28K (CALB1), calbindin-D-29K (CALB2), glutamic acid decarboxylase 67 (GAD67), parvalbumin (PVALB), reelin (RELN), and somatostatin (SST), which are the GABAergic interneuron markers 19,38 ; Fos proto-oncogene, AP-1 transcription factor subunit (FOS), activityregulated cytoskeleton-associated protein (ARC), cyclooxygenase-2 (COX2) and phosphorylated extracellular signal-regulated kinase 1/2 (p-ERK1/2; phosphorylated p44/p42 MAP kinase), which are the markers involved in synaptic plasticity. [39][40][41] Immunohistochemical detection of the antigens was conducted employing an Avidin-Biotin Complex method.…”